ECS-PLEX

Serial Number 88130686
602

Registration Progress

Application Filed
Dec 20, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ECS-PLEX

Basic Information

Serial Number
88130686
Filing Date
December 20, 2018
Abandonment Date
December 8, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 10, 2022
Classes
003 005

Rights Holder

ECS Therapeutics LLC

16
Address
Suite 2
120 Broadhollow Road
Farmingdale, NY 11735

Ownership History

ECS Therapeutics LLC

Original Applicant
16
Farmingdale, NY

Legal Representation

Attorney
Jay A. Bondell, Esq.

USPTO Deadlines

All Deadlines Cleared

All 9 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Mar 10, 2022 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 10, 2022 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jun 7, 2021 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Jun 7, 2021 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Jun 7, 2021 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
May 6, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 5, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 8, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 8, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 8, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 29, 2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 16, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 16, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 16, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Sep 3, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 2, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 2, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 4, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 4, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 10, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 10, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 6, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 3, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 1, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 1, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 8, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 7, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 2, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 28, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 003
Non-medicated skin creams and balms containing cannabis solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Dietary supplements containing cannabis solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing cannabidiol
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
003 005